Agenda

Displaying agenda in the event’s time zone (CET, GMT +2)

CONFERENCE DAY 1
Wednesday, 29 March, 2023
CONFERENCE DAY 2
Thursday, 30 March, 2023
CONFERENCE DAY 3
Friday, 31 March, 2023

REGISTRATION AND NETWORKING BREAKFAST

SYNTHESIZING PRIMARY RESEARCH INTO ACTIONABLE INSIGHTS AND PRESENTATIONS

When it comes to gaining valuable insights from primary research, the challenge lies in synthesizing research data and drawing actionable insights to achieve your research objectives.

The Molekule team will highlight the key considerations in designing primary research projects, synthesizing actionable insights from collected data, and articulating key findings into impactful and strategic presentations leading to a shared understanding.

Presented by Molekule Consulting

COFFEE BREAK

Mastering Timelines Assumptions – A Practical Guide on How to Elevate Your Competitors’ Analysis

An interactive session where the Lifescience Dynamics team will share its knowledge and experience in understanding and evaluating EU regulatory timelines.

• An introduction to EU regulatory pathways and differences to US pathways
• How do we benchmark and make assumptions about EU regulatory timelines?
• Case studies: Examples from past EU approvals

Presented by Lifescience Dynamics

NETWORKING LUNCH

Developing a Competitive Activity Framework to Enhance Organizational Competitiveness

This workshop session will give participants first-hand insights from a combined 30+ years of experience in delivering strategic and tactical workshop-style solutions, using an optimal blend of established CI frameworks alongside INOVIS’ proprietary methodologies.

Key to this session will be addressing business needs across the lifecycle, whereby participants will:
· Develop an in-depth understanding of how a diverse range of facilitated activities (Rapid Immersion, Threat Assessment and Competitor Simulations) can help deliver strategic and competitive insights within an organization
· Appreciate the importance of leveraging the outcomes of workshops to inform and direct decision making
· Receive hands-on opportunities to apply learnings to a pharma case-study in a learning environment
Using business case studies, real-life experiences and validated theory, the INOVIS team will equip you with a number of go-to techniques that can be rapidly integrated into ongoing CI Practice, whether you’re a seasoned CI professional veteran, or newer to the field.

Presented by INOVIS

COFFEE BREAK

Building a Winning Strategy: Turning Insights into Actions

A prescription drug that surpasses $1 billion in sales is known as a blockbuster. It's a rare feat, but when a pharmaceutical company finds a true blockbuster drug they usually have a robust competitive readiness program in place.

Blockbuster Competitive Intelligence is a new framework that almost nobody knows. This framework maximizes the potential of a drug and increases the impact that you can have with competitive intelligence.

So, what is it and how can you leverage it?

Blockbuster Competitive Intelligence outlines how Competitive Intelligence is used to develop, launch, and commercialize a blockbuster drug (or a drug that is critical to the success of the organization).

Over the past two decades, we have worked with multiple blockbusters and potential blockbuster products. We have experimented and innovated successful approaches while working at Roche, and Novartis. With Atacana we continue to innovate and support the majority of the top 10 pharma companies helping their blockbuster competitive intelligence strategies.

In this interactive workshop, we will share with you our Blockbuster Competitive Intelligence framework and learn from other participants what it takes to develop a winning strategy.

Our goal is to help you maximize the potential of your product and your potential for your next career move!

Presented by Atacana Group

MASTERCLASSES CONCLUDE

Good Morning! Registration & Welcome Coffee/ Snacks in Exhibition Hall

Chairpersons’ Opening Remarks

Presented by Novartis and STADA

Keynote: How to Create Highly Engaged Organizations After Pandemic

A talk about the VUCA world we are in and what it means in terms of:

• Leadership
• HR Organization (hybrid working)
• New performance management approach
• New Talent management approach

Presented by Organon

Keynote: Thriving Beyond Uncertainty, Chaos, and Crisis

The world appears to be breaking apart with pandemics, population decline, financial crises, climate impacts, social tensions, and wars.

It is an ongoing rollercoaster that challenges governments, nonprofits, and corporate environments. However, there is always an opportunity to thrive in uncertain times by leveraging key insights into utilizing intelligence about the future to anticipate change, understanding the various types of emergence, and avoiding disruption by imagining and building new global scenarios where humans collaborate with AI to understand emerging issues.

Presented by FFWD

Refresh & Connect in Exhibition Hall

Leveraging Brand Positioning Research Outputs to Outmaneuver Competition

Segmentation and positioning studies have long been a staple for market researchers supporting launch brands.

We will take a fresh look at brand positioning market research and discuss how competitive simulation workshops can be used to elevate the positioning research outputs. With the help of a case study we’ll demonstrate the value of incorporating such workshops into positioning studies right at the planning stage.

Presented by Lifescience Dynamics

DISCOVERING #ADHESION, ROAD TO #ADHERENCE: DIFFERENT PERSPECTIVES, ONE BIG GOAL

Presented by Menarini

Reveal the True Impact of Disease; Using Advanced AI Driven Language Processing to Map the Disease Burden and Health Related Quality of Life

Presented by Real Chemistry

Networking Luncheon

The Truth about How Prescribers Answer Percentage Allocation Questions

In pharmaceutical demand studies, it is common practice to ask prescribers to allocate percentages across treatment options in order to quantify their expected future use of a new product.

However, the decision process that respondents use to determine these percentages are a black box—unknown to the marketing researchers, probably heterogeneous across respondents, and for many respondents, potentially not very accurate. In this presentation, we present the outcomes from original research conducted with prescribers to investigate the decision process and mental calculations that respondents actually use when they answer percentage allocation questions. We show the specific challenges that physicians encounter when responding to these questions and how these challenges translate into significant sources of error in the resulting data. Our presentation concludes with actionable recommendations for improving the accuracy of demand studies.

Presented by AplusA

Conducting Primary Market Research to Improve Clinical Trial Retention and Recruitment

Presented by PharmaValue Partners

The Voice of the Customer

Methodologies and techniques needed to listen to our customer

Presented by Pfizer

Refuel & Rejuvenate in Exhibition Hall

How Integrating Conjoint Can Enhance Your Tracking Research

It would briefly cover fundamentals of conjoint and showcase "real life" application in a tracking programs - tackling some of the key benefits of the approach: More granularity, Going beyond the WHAT and Efficient research.

Presented by Instar and Boehringer Ingelheim

“Ask the Experts” Interactive Roundtables

(Explore and capture the power of participants’ insights and experiences and exploration of these topics in this fun and informal environment in small groups.)
ROUNDTABLE 1
CI Organizational Setup- the Pros and Cons of Different Company Approaches

Presented by Novartis

ROUNDTABLE 2
Insights for New Product and Business Development in a Biotech Startup

Presented by Alentis Therapeutics

ROUNDTABLE 3
Can CI Add Value to Customer Experience?

Presented by Chiesi Farmaceutici S.p.A.

ROUNDTABLE 4
The Role and Position of BI within Project Teams – Expectations vs Reality

• How and to which level is BI is involved in project team activities (regular ones and/or strategic ones)

• Is BI standard part of core project team or only ad hoc guest?
• How do you deliver/report your findings?
• Tips on how to get more involved (proactive vs reactive approach)

Presented by SOTIO, a.s.

ROUNDTABLE 5
The Advantages (and Disadvantages) of Social Media Listening for Market Research

Presented by STADA

ROUNDTABLE 6
Career Development

Presented by Bristol Myers Squibb

Integrating Customer Insights with Competitive Intelligence for a Deeper Market Understanding

To really understand the market dynamics well, one needs to understand the perspectives of customers, competitors, and collaborators.

While market research is squarely focused on the “customers” piece of the equation, competitive intelligence provides crucial insight into the way the market shifts as a result of competitor activity. Through this talk, we explain, with the help of some examples, when and how CI can be interwoven into market research to unlock a unique perspective of the market that is not only more comprehensive but also more forward-looking and actionable.

Presented by Lifescience Dynamics

Cocktail Reception and Networking (sponsored by Lifescience Dynamics)

Good Morning! Registration & Welcome Coffee in Exhibition Hall

Chairpersons’ Opening Remarks

Presented by Novartis and STADA

Keynote: Strategic Decision Making: Turning insights into actions

The aim of competitive intelligence is to help Pharma Leaders to develop a winning strategy.

The traditional CI model of gathering intelligence and generating insights is not enough. Developing, launching and growing blockbuster brands require a well defined strategic decision making process.

In this presentation, we will share our proven 3 step process needed to identify your key competitors, assess several credible scenarios, determine risks and opportunities, identify the key success factors, and create an action plan to execute within your winning strategy.

The presentation incorporates learnings from leading the CI functions at Roche and Novartis, supporting the majority of Big Pharma companies CI efforts, the latest management thinking from Harvard Business School, and years of cross-functional experience within Pharma and at Atacana.

We look forward to seeing you there!

Presented by Atacana Group

Keynote: Changing Behavior Is Hard: Avoid the Dashboard Pitfall by Using NLP in Your Stakeholder Workflows

This session explores the potential failed promise of intelligence dashboards and how the delivery objective should center on the stakeholder workflow, rather than the resource itself. If you’ve just created an internal CI dashboard, are struggling with changing stakeholder behavior, or are considering a budget for dashboard creation, don’t miss this session.

Presented by FENIX and CSL Seqirus

Refresh & Connect in Exhibition Hall

Leveraging Digital Tools For Conference Coverage: ASCO 2022 case study

• Challenges faced by pharma teams with respect to conference preparation and coverage

• Information management from public domain: sifting through the ‘noise’
• Using the hybrid of technology and human touch to create successful outcomes
• Case study: ASCO2022

Presented by Larvol

An Interactive Session Exploring the Main Trends in the Life Science & Healthcare Industry and How CI can Support Organisations Staying Ahead of the Curve

Presented by Deallus

Future Impact of AI and ML in the Pharma Industry

Presented by GlaxoSmithKline

Networking Luncheon

“Ask the Experts” Interactive Roundtables

(Explore and capture the power of participants’ insights and experiences and exploration of these topics in this fun and informal environment in small groups.)
ROUNDTABLE 1
CI Organizational Setup- the Pros and Cons of Different Company Approaches

Presented by Novartis

ROUNDTABLE 2
Insights for New Product and Business Development in a Biotech Startup

Presented by Alentis Therapeutics

ROUNDTABLE 3
The Role and Position of BI within Project Teams – Expectations vs Reality

• How and to which level is BI is involved in project team activities (regular ones and/or strategic ones)

• Is BI standard part of core project team or only ad hoc guest?
• How do you deliver/report your findings?
• Tips on how to get more involved (proactive vs reactive approach)

Presented by SOTIO, a.s.

ROUNDTABLE 4
Global to Local Forecasting

Presented by Bristol Myers Squibb and Menarini

Enterprise Intelligence: A Lone Wolf Activity, or a Corporate Capability?

Presented by Novartis

But How Do You Feel? Using Neuromarketing Techniques to Understand Unconscious Emotions in Medical Decision Making and Communication

Medical decision making is often driven by unconscious emotional responses, yet traditional marketing techniques often fail to tap into these underlying drivers. Consumer Neuroscience techniques, such as fMRI-based analyses, provide a unique opportunity to gain insights into the emotional components of medical decision making, both for physicians and patients.

In this talk, we will explore the use of neuromarketing techniques in the medical industry and how they can help us understand the unconscious emotions that influence medical decision making. We will present a series of case studies that reveal the emotional components driving medical decision making, and explore how this knowledge can be used to improve marketing strategies and communication in the medical industry.

Moreover, we will discuss the challenges of implementing neuromarketing techniques in the medical industry, including ethical considerations and the need for specialized training. However, the potential benefits of using these techniques to understand the unconscious emotions of patients and physicians far outweigh these challenges.

By the end of this talk, attendees will have a greater understanding of how neuromarketing techniques can be used to understand unconscious emotions in medical decision making. They will also gain insights into how to develop more effective marketing strategies and communication that appeal to the emotional and intuitive responses of both physicians and patients, ultimately leading to more successful engagement and increased sales.

Overall, this talk will provide valuable insights into the power of neuromarketing techniques to improve marketing and communication in the medical industry, and how understanding the unconscious emotions of patients and physicians is key to success in this field.

Presented by University of Amsterdam

Closing Remarks from Co-Chairs

Presented by Novartis and STADA

Conference Concludes